FSSNX
Price
$27.77
Change
-$0.31 (-1.10%)
Updated
Sep 20 closing price
SSRRX
Price
$6.61
Change
-$0.03 (-0.45%)
Updated
Sep 20 closing price
Ad is loading...

FSSNX vs SSRRX

Header iconFSSNX vs SSRRX Comparison
Open Charts FSSNX vs SSRRXBanner chart's image
Fidelity Small Cap Index
Price$27.77
Change-$0.31 (-1.10%)
VolumeN/A
CapitalizationN/A
Touchstone Small Company R6
Price$6.61
Change-$0.03 (-0.45%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSSNX vs SSRRX Comparison Chart
Loading...
VS
FSSNX vs. SSRRX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and SSRRX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. SSRRX (1.16B). FSSNX pays higher dividends than SSRRX: FSSNX (1.36) vs SSRRX (0.00). FSSNX was incepted earlier than SSRRX: FSSNX (13 years) vs SSRRX (10 years). SSRRX is a more actively managed with annual turnover of: 94.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than SSRRX: FSSNX (0) vs SSRRX (50000). FSSNX (22.65) and SSRRX (22.39) have marching annual gain over last year. FSSNX return over 5 years is better than : 44.62 vs. SSRRX (34.43).
FSSNXSSRRXFSSNX / SSRRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years10 years-
Gain YTD9.97211.37588%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets27.3B1.16B2,349%
Annual Yield % from dividends1.360.00-
Returns for 1 year22.6522.39101%
Returns for 3 years0.65-5.07-13%
Returns for 5 years44.6234.43130%
Returns for 10 years84.24N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XCUR2.290.08
+3.62%
Exicure Inc
JAMF17.950.59
+3.40%
Jamf Holding Corp
WPP49.920.72
+1.46%
WPP PLC
CELC15.010.03
+0.20%
Celcuity
CKPT2.46-0.06
-2.38%
Checkpoint Therapeutics